Dr. Luc Van Driessche Cardiologie
0896.886.348 · rovalta.com · 27/09/2026
Dr. Luc Van Driessche Cardiologie
Financial year 2025 · Closed on 31/12/2025
Overview
Identity
Source · BCE/KBODr. Luc Van Driessche Cardiologie is a Private limited company incorporated in 2008. Its registered office is in Lokeren.
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0896.886.348
- Incorporation
- 02/04/2008
- Legal form
- Private limited company
- Registered office
- Schoolstraat 34
9160 Lokeren · FlandreSee on map - Contributed capital
- 12 400,00 €
- Latest accounts
- 31/12/2025
Financials
Source · NBB, 18 filingsTrend over 18 financial years
| 2025 | 2024 | 2023 | 2022 | 2021 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Gross margin | 469,8 k € | +2.5% | 458,3 k € | -16.8% | 550,8 k € | +2.9% | 535 k € | +40.2% | 381,5 k € |
| EBITDA | 468,8 k € | +2.9% | 455,4 k € | -17.0% | 548,6 k € | +3.0% | 532,6 k € | +40.8% | 378,3 k € |
| Operating result | 436 k € | +2.9% | 423,6 k € | -18.2% | 517,7 k € | +1.0% | 512,6 k € | +43.1% | 358,3 k € |
| Net result | 319,2 k € | +3.4% | 308,8 k € | -14.1% | 359,6 k € | +1.3% | 354,9 k € | +43.5% | 247,4 k € |
| Balance sheet | |||||||||
| Equity | 1,8 M € | +6.3% | 1,7 M € | -7.3% | 1,9 M € | +24.0% | 1,5 M € | +9.8% | 1,4 M € |
| Total assets | 1,9 M € | +3.7% | 1,8 M € | -7.1% | 2 M € | +15.8% | 1,7 M € | +15.5% | 1,5 M € |
| Cash | 413,3 k € | -39.2% | 679,7 k € | -15.7% | 806,7 k € | -39.0% | 1,3 M € | +1.6% | 1,3 M € |
| Debts | 51 k € | -44.7% | 92,2 k € | -3.5% | 95,6 k € | -49.4% | 189 k € | +96.4% | 96,2 k € |
Valuation
Indicative valuation
As an indication, this company is worth
Board of directors
Source · NBB, accounts to 31/12/20251 active · 1 ended
Active mandates
Ended mandates
Financials
Full financial information
Source · NBB| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Type of account | Micro model | Micro model | Micro model | Micro model | Micro model | Micro model |
| Start of the financial year | 01/01/2025 | 01/01/2024 | 01/01/2023 | 01/01/2022 | 01/01/2021 | 01/01/2020 |
| Closing of the financial year | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 | 31/12/2020 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 27/07/2026 | 28/07/2025 | 16/08/2024 | 31/08/2023 | 20/07/2022 | 30/08/2021 |
| General meeting | 30/06/2026 | 30/06/2025 | 30/06/2024 | 30/06/2023 | 29/06/2022 | 01/06/2021 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for freeAnnual accounts filings
Source · NBB, 18 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Micro model | 31/12/2025 | 30/06/2026 | 27/07/2026 | Dutch | |
| Micro model | 31/12/2024 | 30/06/2025 | 28/07/2025 | Dutch | |
| Micro model | 31/12/2023 | 30/06/2024 | 16/08/2024 | Dutch | |
| Micro model | 31/12/2022 | 30/06/2023 | 31/08/2023 | Dutch | |
| Micro model | 31/12/2021 | 29/06/2022 | 20/07/2022 | Dutch | |
| Micro model | 31/12/2020 | 01/06/2021 | 30/08/2021 | Dutch | |
| Micro model | 31/12/2019 | 02/06/2020 | 29/06/2020 | Dutch | |
| Micro model | 31/12/2018 | 29/06/2019 | 29/08/2019 | Dutch | |
| Micro model | 31/12/2017 | 28/06/2018 | 19/07/2018 | Dutch | |
| Micro model | 31/12/2016 | 29/06/2017 | 17/07/2017 | Dutch | |
| Abridged model | 31/12/2015 | 30/06/2016 | 12/08/2016 | Dutch | |
| Abridged model | 31/12/2014 | 29/06/2015 | 30/07/2015 | Dutch | |
| Abridged model | 31/12/2013 | 31/07/2014 | 02/09/2014 | Dutch | |
| Abridged model | 31/12/2012 | 28/06/2013 | 24/07/2013 | Dutch | |
| Abridged model | 31/12/2011 | 29/06/2012 | 25/07/2012 | Dutch | |
| Abridged model | 31/12/2010 | 30/06/2011 | 29/07/2011 | Dutch | |
| Abridged model | 31/12/2009 | 30/06/2010 | 28/07/2010 | Dutch | |
| Abridged model | 31/12/2008 | 02/06/2009 | 11/08/2009 | Dutch |
Valuation
Indicative valuation
As an indication, this company is worth
between 2,5 M€ and 5 M€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 31/12/20251 active · 1 ended
Active mandates
Ended mandates
Ownership and network
Looking for more information about this company?
Try for freePublications
Belgian Official Gazette publications
Source · Belgian Official GazetteSimilar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2025Annual accounts 2025319,2 k €↑
- 2024Annual accounts 2024308,8 k €↓
- 2023Annual accounts 2023359,6 k €↑
- 2023Name changeVAN DRIESSCHE LUC CARDIOLOGIE DR.
- 2022Annual accounts 2022354,9 k €↑
- 2021Annual accounts 2021247,4 k €↑
- 2021Name changeDr. Luc Van Driessche Cardiologie
- 2020Annual accounts 2020206,1 k €↓
- 2019Annual accounts 2019210,2 k €↓
- 2018Annual accounts 2018226,2 k €↑
- 2017Annual accounts 2017217,4 k €↓
- 2016Annual accounts 2016221 k €↑
- 2015Annual accounts 2015145,4 k €↓
- 2014Annual accounts 2014196,9 k €↓
- 2013Annual accounts 2013220,8 k €↑
- 2012Annual accounts 2012213 k €↑
- 2011Annual accounts 2011173,7 k €↓
- 2010Annual accounts 2010186,4 k €↑
- 2009Annual accounts 2009116,5 k €↑
- 2008Annual accounts 200827,3 k €
- 02/04/2008IncorporationPrivate limited company